Belgium / Fierce Pharma
gsk.
Headlines and brief publisher-provided excerpts about gsk, with links to the original reports.
Publisher coverage
From Fierce Pharma.
GSK commits $800M to R&D, manufacturing hub, as Pennsylvania bonds deepen
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPRXFfRnVwcmdPcHpJeUUxTXhZTkUwaHZlbWF0aEVTODEzWDB2VG5wZFRjZ2pXV2pHaExJMFlhMmlaZXdqRUQ1T0ZRSC1veHlVZkRqcGNUV1lfVHNDdWQ1YUxMTFluT0tXOVR6bnpXQkhnSEs0VzBGMTJORkphU19CdHlXZVpQQThZV3hkRkFMWWNNX0w0QkhKbVNETmdsdUF6?oc=5" target="_blank">GSK commits $800M to R&D, manufacturing hub, as Pennsylvania bonds deepen</a> <font color="#6f6f6f">Fierce Pharma</font>
Read the original reportGSK slammed for ‘grossly misleading’ and ‘totally unacceptable’ behavior
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxNaV9uaGZYdlkzNkVQSjd0dTJNNHNkdmtkMWRUbXl2c0o5STV2LVJXYkUxbWlXaDUwQ1VjWGlZa1RzSnJfTENzc2g4b2FLR2IxN0FuWG5pY1NNWFlETC1CNjBPZ24xcno0LS1MUmlZZ0pab0F4eHNEbW5HZkZ4TDEyQU1NODF1WmpldlZDMGxsVDlSVDRVSHM0b1h3Q2Q4TVBpQW03d1hn?oc=5" target="_blank">GSK slammed for ‘grossly misleading’ and ‘totally unacceptable’ behavior</a> <font color="#6f6f6f">Fierce Pharma</font>
Read the original report